Literature DB >> 21843919

Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen.

M Kontos1, D S Allen, O F Agbaje, H Hamed, I S Fentiman.   

Abstract

BACKGROUND: In breast cancer patients (≥70 years), tumour resection plus tamoxifen (T + T) has a higher loco-regional relapse (LR) rate than mastectomy. This study examines factors influencing local recurrence in these cases.
METHODS: Clinical records of 71 patients aged ≥70 years, randomised to the T + T arm of 2 randomised trials were reviewed. Cox Proportional Hazards model was used to determine the most significant variables.
RESULTS: After 15-years follow-up, LR relapse occurred in 29/71, of whom 5 had synchronous metastatic disease. Most tumours recurred in the index quadrant. Subsequently 21/24 patients with loco-regional recurrence only had salvage mastectomy. Three variables significantly predicted LR: lympho-vascular invasion (LVI) (HR [95% CI]: 11.18 [4.47, 27.95], p < 0.01), ER negative status (HR [95% CI]: 0.27 [0.10, 0.72] p = 0.01), and tumour necrosis (HR [95% CI]: 2.65 [1.10, 6.37], p = 0.03). Final margin status was not associated with LR.
CONCLUSIONS: Tumour resection + Tamoxifen in older patients results in long-term local control in the majority with most loco-regional failures being salvageable. Risk factors for LR are lympho-vascular invasion, ER status and tumour necrosis. Negative tumour excision margins did not significantly change local outcome in the absence of radiotherapy. In these older patients LVI significantly reduced survival time.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21843919     DOI: 10.1016/j.ejso.2011.07.005

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  5 in total

1.  Impact of Older Age and Comorbidity on Locoregional and Distant Breast Cancer Recurrence: A Large Population-Based Study.

Authors:  Anna Z de Boer; Heleen C van der Hulst; Nienke A de Glas; Perla J Marang-van de Mheen; Sabine Siesling; Linda de Munck; Kelly M de Ligt; Johanneke E A Portielje; Esther Bastiaannet; Gerrit Jan Liefers
Journal:  Oncologist       Date:  2019-09-12

Review 2.  Breast cancer under age 40: a different approach.

Authors:  D Ribnikar; J M Ribeiro; D Pinto; B Sousa; A C Pinto; E Gomes; E C Moser; M J Cardoso; F Cardoso
Journal:  Curr Treat Options Oncol       Date:  2015-04

Review 3.  Management of operable breast cancer in older women.

Authors:  Ian S Fentiman
Journal:  J R Soc Med       Date:  2013-01       Impact factor: 5.344

4.  The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects.

Authors:  A Wöckel; R Wolters; T Wiegel; I Novopashenny; W Janni; R Kreienberg; M Wischnewsky; L Schwentner
Journal:  Ann Oncol       Date:  2014-02-09       Impact factor: 32.976

5.  Symptomatic metastasis prediction with serial measurements of CA 15.3 in primary breast cancer patients.

Authors:  Amir Bahrami-Ahmadi; Fariborz Makarian; Mohammad R Mortazavizadeh; Mohammad F Yazdi; Mehdi Chamani
Journal:  J Res Med Sci       Date:  2012-09       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.